(Q37165025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

title

Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures -- a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

main subject

virology

0 references

anti-retroviral agent

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Rebecca Hammond

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

International Journal of STD & AIDS

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

291-296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

Tolerance and acceptability of an efavirenz-based regimen in 740 adults (predominantly women) in West Africa

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Preventing antiretroviral anarchy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

How to read a paper. Getting your bearings (deciding what the paper is about)

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Antiretroviral therapy in a primary care clinic in rural South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

Adherence is not a barrier to successful antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2007.007248

21 January 2018

Identifiers

DOI

10.1258/IJSA.2007.007248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18482957%20AND%20SRC:MED&resulttype=core&format=json

release_zpdvgrm2abaubc4o3ena2yrcke

7 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zpdvgrm2abaubc4o3ena2yrcke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference